Assessment of survival outcomes among lung cancer patients at the National and Referral Hospital in Kenya

Abstract Introduction Lung cancer has a low overall survival rate linked to late diagnosis and metastasis. Unfortunately, comprehensive data within the African continent are limited due to the lack of a registry, low public awareness of lung cancer, financial constraints, and inadequate screening an...

Full description

Bibliographic Details
Main Authors: Nur Swaleh Said, Amsalu Degu
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.5658
_version_ 1797831031609360384
author Nur Swaleh Said
Amsalu Degu
author_facet Nur Swaleh Said
Amsalu Degu
author_sort Nur Swaleh Said
collection DOAJ
description Abstract Introduction Lung cancer has a low overall survival rate linked to late diagnosis and metastasis. Unfortunately, comprehensive data within the African continent are limited due to the lack of a registry, low public awareness of lung cancer, financial constraints, and inadequate screening and treatment facilities. In addition, there was a lack of conclusive data in our setting. Therefore, this study aimed to assess survival outcomes among lung cancer patients at Kenyatta National Hospital. Methods A hospital‐based retrospective cohort study was performed to examine the survival outcomes of 151 lung cancer patients. All eligible lung cancer patients diagnosed and treated in the facility between January 1, 2018, and December 31, 2020, were included. The patients were retrospectively followed from the date of primary cancer diagnosis until death or the last follow‐up period. The Statistical Package for the Social Sciences (SPSS) version 20.0 statistical software was used to enter and analyze the data. Kaplan–Meier survival and Cox regression analysis were employed to determine median survival and predictors of mortality, respectively. Results The mean and median follow‐time was 18.2 and 17.5 months, respectively. Most (98%) of the patients had non‐small cell lung cancer. The 2‐year survival rate was 66.7%, with 59.6% of patients having developed distant metastasis during the follow‐up, while 25.1% were deceased. The median cancer‐specific survival time among the study population was 18.0 ± 3.40 months. Cox regression analyses showed that patients with distant metastasis had five times more risk of dying (AHR: 4.74, 95% CI: 2.1–10.8, p < 0.001) than patients without distant metastasis. Conclusions The overall two‐year survival rate of lung cancer patients at the Kenyatta National Hospital was 66.7%, with most patients developed distant metastasis during the follow‐up period. Distant metastasis was the only significant predictor of mortality among lung cancer patients in our setting.
first_indexed 2024-04-09T13:45:34Z
format Article
id doaj.art-12ea0928d2514bbf9d9b6b409919b2a9
institution Directory Open Access Journal
issn 2045-7634
language English
last_indexed 2024-04-09T13:45:34Z
publishDate 2023-04-01
publisher Wiley
record_format Article
series Cancer Medicine
spelling doaj.art-12ea0928d2514bbf9d9b6b409919b2a92023-05-09T04:04:18ZengWileyCancer Medicine2045-76342023-04-011289194920110.1002/cam4.5658Assessment of survival outcomes among lung cancer patients at the National and Referral Hospital in KenyaNur Swaleh Said0Amsalu Degu1Department of Pharmaceutics and Pharmacy Practice School of Pharmacy and Health Sciences, United States International University‐Africa Nairobi KenyaDepartment of Pharmaceutics and Pharmacy Practice School of Pharmacy and Health Sciences, United States International University‐Africa Nairobi KenyaAbstract Introduction Lung cancer has a low overall survival rate linked to late diagnosis and metastasis. Unfortunately, comprehensive data within the African continent are limited due to the lack of a registry, low public awareness of lung cancer, financial constraints, and inadequate screening and treatment facilities. In addition, there was a lack of conclusive data in our setting. Therefore, this study aimed to assess survival outcomes among lung cancer patients at Kenyatta National Hospital. Methods A hospital‐based retrospective cohort study was performed to examine the survival outcomes of 151 lung cancer patients. All eligible lung cancer patients diagnosed and treated in the facility between January 1, 2018, and December 31, 2020, were included. The patients were retrospectively followed from the date of primary cancer diagnosis until death or the last follow‐up period. The Statistical Package for the Social Sciences (SPSS) version 20.0 statistical software was used to enter and analyze the data. Kaplan–Meier survival and Cox regression analysis were employed to determine median survival and predictors of mortality, respectively. Results The mean and median follow‐time was 18.2 and 17.5 months, respectively. Most (98%) of the patients had non‐small cell lung cancer. The 2‐year survival rate was 66.7%, with 59.6% of patients having developed distant metastasis during the follow‐up, while 25.1% were deceased. The median cancer‐specific survival time among the study population was 18.0 ± 3.40 months. Cox regression analyses showed that patients with distant metastasis had five times more risk of dying (AHR: 4.74, 95% CI: 2.1–10.8, p < 0.001) than patients without distant metastasis. Conclusions The overall two‐year survival rate of lung cancer patients at the Kenyatta National Hospital was 66.7%, with most patients developed distant metastasis during the follow‐up period. Distant metastasis was the only significant predictor of mortality among lung cancer patients in our setting.https://doi.org/10.1002/cam4.5658KenyaKenyatta National Hospitallung cancersurvival outcomes
spellingShingle Nur Swaleh Said
Amsalu Degu
Assessment of survival outcomes among lung cancer patients at the National and Referral Hospital in Kenya
Cancer Medicine
Kenya
Kenyatta National Hospital
lung cancer
survival outcomes
title Assessment of survival outcomes among lung cancer patients at the National and Referral Hospital in Kenya
title_full Assessment of survival outcomes among lung cancer patients at the National and Referral Hospital in Kenya
title_fullStr Assessment of survival outcomes among lung cancer patients at the National and Referral Hospital in Kenya
title_full_unstemmed Assessment of survival outcomes among lung cancer patients at the National and Referral Hospital in Kenya
title_short Assessment of survival outcomes among lung cancer patients at the National and Referral Hospital in Kenya
title_sort assessment of survival outcomes among lung cancer patients at the national and referral hospital in kenya
topic Kenya
Kenyatta National Hospital
lung cancer
survival outcomes
url https://doi.org/10.1002/cam4.5658
work_keys_str_mv AT nurswalehsaid assessmentofsurvivaloutcomesamonglungcancerpatientsatthenationalandreferralhospitalinkenya
AT amsaludegu assessmentofsurvivaloutcomesamonglungcancerpatientsatthenationalandreferralhospitalinkenya